These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 25766632)

  • 21. Thiophene bioisosteres of spirocyclic sigma receptor ligands. 1. N-substituted spiro[piperidine-4,4'-thieno[3,2-c]pyrans].
    Oberdorf C; Schepmann D; Vela JM; Diaz JL; Holenz J; Wünsch B
    J Med Chem; 2008 Oct; 51(20):6531-7. PubMed ID: 18816044
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery and synthesis of cyclohexenyl derivatives as modulators of CC chemokine receptor 2 activity.
    Brown GD; Shi Q; Delucca GV; Batt DG; Galella MA; Cvijic ME; Liu RQ; Qiu F; Zhao Q; Barrish JC; Carter PH
    Bioorg Med Chem Lett; 2016 Jan; 26(2):662-666. PubMed ID: 26631321
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and structure-activity relationship of 7-azaindole piperidine derivatives as CCR2 antagonists.
    Xia M; Hou C; DeMong D; Pollack S; Pan M; Singer M; Matheis M; Murray W; Cavender D; Wachter M
    Bioorg Med Chem Lett; 2008 Dec; 18(24):6468-70. PubMed ID: 18990568
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of (4-Arylpiperidin-1-yl)cyclopentanecarboxamides As High-Affinity and Long-Residence-Time Antagonists for the CCR2 Receptor.
    Vilums M; Zweemer AJ; Dilanchian A; van Veldhoven JP; de Vries H; Brussee J; Saunders J; Stamos D; Heitman LH; IJzerman AP
    ChemMedChem; 2015 Jul; 10(7):1249-58. PubMed ID: 26033831
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Capped diaminopropionamide-glycine dipeptides are inhibitors of CC chemokine receptor 2 (CCR2).
    Carter PH; Brown GD; Friedrich SR; Cherney RJ; Tebben AJ; Lo YC; Yang G; Jezak H; Solomon KA; Scherle PA; Decicco CP
    Bioorg Med Chem Lett; 2007 Oct; 17(19):5455-61. PubMed ID: 17720492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure-Affinity Relationships of Fluorinated Spirocyclic σ
    Bergkemper M; Kronenberg E; Schepmann D; Ludwig FA; Brust P; Wünsch B
    ChemMedChem; 2019 Aug; 14(15):1392-1402. PubMed ID: 31189022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and pharmacological evaluation of 1,2-dihydrospiro[isoquinoline-4(3H),4'-piperidin]-3-ones as nociceptin receptor agonists.
    Mustazza C; Borioni A; Sestili I; Sbraccia M; Rodomonte A; Del Giudice MR
    J Med Chem; 2008 Feb; 51(4):1058-62. PubMed ID: 18232652
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure of CC chemokine receptor 2 with orthosteric and allosteric antagonists.
    Zheng Y; Qin L; Zacarías NV; de Vries H; Han GW; Gustavsson M; Dabros M; Zhao C; Cherney RJ; Carter P; Stamos D; Abagyan R; Cherezov V; Stevens RC; IJzerman AP; Heitman LH; Tebben A; Kufareva I; Handel TM
    Nature; 2016 Dec; 540(7633):458-461. PubMed ID: 27926736
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological profile of JNJ-27141491 [(S)-3-[3,4-difluorophenyl)-propyl]-5-isoxazol-5-yl-2-thioxo-2,3-dihydro-1H-imidazole-4-carboxyl acid methyl ester], as a noncompetitive and orally active antagonist of the human chemokine receptor CCR2.
    Buntinx M; Hermans B; Goossens J; Moechars D; Gilissen RA; Doyon J; Boeckx S; Coesemans E; Van Lommen G; Van Wauwe JP
    J Pharmacol Exp Ther; 2008 Oct; 327(1):1-9. PubMed ID: 18599682
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, synthesis and structure activity relationships of spirocyclic compounds as potent CCR1 antagonists.
    Hossain N; Ivanova S; Bergare J; Mensonides-Harsema M; Cooper ME
    Bioorg Med Chem Lett; 2013 Jun; 23(12):3500-4. PubMed ID: 23659855
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elucidation of binding sites of dual antagonists in the human chemokine receptors CCR2 and CCR5.
    Hall SE; Mao A; Nicolaidou V; Finelli M; Wise EL; Nedjai B; Kanjanapangka J; Harirchian P; Chen D; Selchau V; Ribeiro S; Schyler S; Pease JE; Horuk R; Vaidehi N
    Mol Pharmacol; 2009 Jun; 75(6):1325-36. PubMed ID: 19297521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thiophene bioisosteres of spirocyclic σ receptor ligands: relationships between substitution pattern and σ receptor affinity.
    Oberdorf C; Schepmann D; Vela JM; Buschmann H; Holenz J; Wünsch B
    J Med Chem; 2012 Jun; 55(11):5350-60. PubMed ID: 22515405
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, synthesis and structure-activity relationships of zwitterionic spirocyclic compounds as potent CCR1 antagonists.
    Hossain N; Ivanova S; Timén ÅS; Bergare J; Mussie T; Bergström L
    Bioorg Med Chem Lett; 2013 Jul; 23(14):4026-30. PubMed ID: 23769642
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and structure-affinity relationships of novel spirocyclic sigma receptor ligands with furopyrazole structure.
    Schläger T; Schepmann D; Würthwein EU; Wünsch B
    Bioorg Med Chem; 2008 Mar; 16(6):2992-3001. PubMed ID: 18221879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery of 3,5-bis(trifluoromethyl)benzyl L-arylglycinamide based potent CCR2 antagonists.
    Yang L; Zhou C; Guo L; Morriello G; Butora G; Pasternak A; Parsons WH; Mills SG; MacCoss M; Vicario PP; Zweerink H; Ayala JM; Goyal S; Hanlon WA; Cascieri MA; Springer MS
    Bioorg Med Chem Lett; 2006 Jul; 16(14):3735-9. PubMed ID: 16698264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alpha-aminothiazole-gamma-aminobutanoic amides as potent, small molecule CCR2 receptor antagonists.
    Zhou C; Guo L; Parsons WH; Mills SG; MacCoss M; Vicario PP; Zweerink H; Cascieri MA; Springer MS; Yang L
    Bioorg Med Chem Lett; 2007 Jan; 17(2):309-14. PubMed ID: 17092717
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of dynamin prevents CCL2-mediated endocytosis of CCR2 and activation of ERK1/2.
    García Lopez MA; Aguado Martínez A; Lamaze C; Martínez-A C; Fischer T
    Cell Signal; 2009 Dec; 21(12):1748-57. PubMed ID: 19643177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. When structure-affinity relationships meet structure-kinetics relationships: 3-((Inden-1-yl)amino)-1-isopropyl-cyclopentane-1-carboxamides as CCR2 antagonists.
    Vilums M; Zweemer AJ; Barmare F; van der Gracht AM; Bleeker DC; Yu Z; de Vries H; Gross R; Clemens J; Krenitsky P; Brussee J; Stamos D; Saunders J; Heitman LH; IJzerman AP
    Eur J Med Chem; 2015 Mar; 93():121-34. PubMed ID: 25666912
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel sulfone-containing di- and trisubstituted cyclohexanes as potent CC chemokine receptor 2 (CCR2) antagonists.
    Cherney RJ; Mo R; Meyer DT; Voss ME; Lo YC; Yang G; Miller PB; Scherle PA; Tebben AJ; Carter PH; Decicco CP
    Bioorg Med Chem Lett; 2009 Jul; 19(13):3418-22. PubMed ID: 19481449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery of INCB3344, a potent, selective and orally bioavailable antagonist of human and murine CCR2.
    Xue CB; Wang A; Meloni D; Zhang K; Kong L; Feng H; Glenn J; Huang T; Zhang Y; Cao G; Anand R; Zheng C; Xia M; Han Q; Robinson DJ; Storace L; Shao L; Li M; Brodmerkel CM; Covington M; Scherle P; Diamond S; Yeleswaram S; Vaddi K; Newton R; Hollis G; Friedman S; Metcalf B
    Bioorg Med Chem Lett; 2010 Dec; 20(24):7473-8. PubMed ID: 21036044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.